FDA approves GW Pharmaceuticals’ CBD drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication.

FDA approves GW Pharmaceuticals’ CBD drug for new indication is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs